Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ULTRALYD OG RØNTGENKLINIKKEN ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7%   Bankruptcy risk   1.5% 1.4% 1.2% 1.7% 1.9% 1.1% 11.6% 11.6%   Credit score (0-100)   77 79 81 72 68 83 21 21   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   18.6 38.1 174.8 3.4 1.0 221.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   8,754 9,007 9,050 9,368 9,726 9,869 9,869 9,869   Gross profit   6,641 6,184 7,040 6,731 6,849 7,068 0.0 0.0   EBITDA   3,238 2,693 3,697 2,461 2,383 3,494 0.0 0.0   EBIT   2,515 1,578 3,254 2,022 2,007 3,144 0.0 0.0   Pre-tax profit (PTP)   2,464.5 1,638.5 3,533.4 1,659.9 2,282.8 3,556.7 0.0 0.0   Net earnings   1,916.9 1,274.9 2,761.6 1,298.0 1,779.5 2,775.5 0.0 0.0   Pre-tax profit without non-rec. items   2,464 1,638 3,533 1,660 2,283 3,557 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   1,725 733 1,371 932 557 1,275 0.0 0.0   Shareholders equity total   2,231 1,606 3,117 2,415 2,995 4,060 1,235 1,235   Interest-bearing liabilities   1,771 1,651 314 379 0.0 4.1 0.0 0.0   Balance sheet total (assets)   4,930 4,357 5,608 3,486 4,124 6,316 1,235 1,235   Net Debt   -34.9 953 -1,237 -1,676 -2,101 -3,039 -1,235 -1,235     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   8,754 9,007 9,050 9,368 9,726 9,869 9,869 9,869   Net sales growth   -10.0% 2.9% 0.5% 3.5% 3.8% 1.5% 0.0% 0.0%   Gross profit   6,641 6,184 7,040 6,731 6,849 7,068 0.0 0.0   Gross profit growth   -13.6% -6.9% 13.8% -4.4% 1.7% 3.2% -100.0% 0.0%   Employees   5 5 4 6 6 5 0 0   Employee growth %   0.0% 0.0% -20.0% 50.0% 0.0% -16.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,930 4,357 5,608 3,486 4,124 6,316 1,235 1,235   Balance sheet change%   -8.9% -11.6% 28.7% -37.8% 18.3% 53.2% -80.4% 0.0%   Added value   3,238.5 2,692.9 3,696.8 2,460.9 2,445.9 3,494.1 0.0 0.0   Added value %   37.0% 29.9% 40.8% 26.3% 25.1% 35.4% 0.0% 0.0%   Investments   -1,447 -2,107 196 -877 -751 369 -1,275 0   Net sales trend   -1.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   37.0% 29.9% 40.8% 26.3% 24.5% 35.4% 0.0% 0.0%   EBIT %   28.7% 17.5% 36.0% 21.6% 20.6% 31.9% 0.0% 0.0%   EBIT to gross profit (%)   37.9% 25.5% 46.2% 30.0% 29.3% 44.5% 0.0% 0.0%   Net Earnings %   21.9% 14.2% 30.5% 13.9% 18.3% 28.1% 0.0% 0.0%   Profit before depreciation and extraordinary items %   30.2% 26.5% 35.4% 18.5% 22.2% 31.7% 0.0% 0.0%   Pre tax profit less extraordinaries %   28.2% 18.2% 39.0% 17.7% 23.5% 36.0% 0.0% 0.0%   ROA %   48.6% 37.2% 71.6% 47.5% 60.4% 68.4% 0.0% 0.0%   ROI %   63.8% 47.6% 106.7% 69.4% 79.4% 101.1% 0.0% 0.0%   ROE %   82.5% 66.5% 116.9% 46.9% 65.8% 78.7% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   45.2% 36.9% 55.6% 69.3% 72.6% 64.3% 100.0% 100.0%   Relative indebtedness %   30.8% 30.5% 27.5% 11.4% 11.6% 22.9% 0.0% 0.0%   Relative net indebtedness %   10.2% 22.8% 10.4% -10.5% -10.0% -8.0% -12.5% -12.5%   Net int. bear. debt to EBITDA, %   -1.1% 35.4% -33.5% -68.1% -88.2% -87.0% 0.0% 0.0%   Gearing %   79.4% 102.8% 10.1% 15.7% 0.0% 0.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.1% 5.1% 3.6% 144.7% 8.4% 634.3% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.9 0.6 0.8 2.3 3.1 2.2 0.0 0.0   Current Ratio   0.9 0.6 0.8 2.3 3.1 2.2 0.0 0.0   Cash and cash equivalent   1,806.4 697.9 1,551.0 2,054.9 2,100.8 3,043.1 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   14.0 13.7 12.7 12.3 11.9 17.1 0.0 0.0   Trade creditors turnover (days)   9.7 7.3 157.4 7.8 15.0 163.8 0.0 0.0   Current assets / Net sales %   26.9% 16.9% 20.9% 26.4% 35.8% 50.2% 12.5% 12.5%   Net working capital   -341.5 -1,089.8 -599.5 -387.6 305.3 277.1 0.0 0.0   Net working capital %   -3.9% -12.1% -6.6% -4.1% 3.1% 2.8% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   1,751 1,801 2,262 1,561 1,621 1,974 0 0   Added value / employee   648 539 924 410 408 699 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   648 539 924 410 397 699 0 0   EBIT / employee   503 316 814 337 335 629 0 0   Net earnings / employee   383 255 690 216 297 555 0 0